Trpv1 agonists, formulations containing them and uses thereof

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 235/28 (2006.01) A61K 31/16 (2006.01) A61P 13/00 (2006.01) A61P 25/00 (2006.01) C07C 235/26 (2006.01) C07D 303/46 (2006.01)

Patent

CA 2575341

The compounds of the general formula (I) in which X is represents two hydrogen atoms, a .pi.-bond, oxygen or methylene; R2 is a C6-C12 aryl, or arylalkyl residue; R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.

L'invention concerne des composés représentés par la formule générale (I), dans laquelle X représente deux atomes d'hydrogène, une liaison p, oxygène ou méthylène; R2 représente aryle C6-C12 ou un résidu arylalkyle ; R3 représente hydrogène, 2-hydroxyéthyle ou 2-aminoéthyle. Ces composés sont utiles pour le traitement d'états pathologiques médiées par des récepteurs vanilloïdes du type I.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Trpv1 agonists, formulations containing them and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Trpv1 agonists, formulations containing them and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trpv1 agonists, formulations containing them and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1791566

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.